CFGS
MRVI icon

Concourse Financial Group Securities’s Maravai LifeSciences MRVI Stock Holding History

Concourse Financial Group Securities’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-29
Closed -$1.42K – 2459
2021
Q2 		$1K Sell
29
-12
-29% -$465 ﹤0.01% 2299
2021
Q1 		$1K Sell
41
-61
-60% -$2.02K ﹤0.01% 2263
2020
Q4 		$3K Buy
+102
New +$2.84K ﹤0.01% 2037

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Concourse Financial Group Securities's MRVI Position: Q3 2021 in Review

Concourse Financial Group Securities sold out of Maravai LifeSciences (MRVI) in Q3 2021, closing a stake of 29 shares — an estimated $1.42K sold.

Concourse Financial Group Securities first reported a position in MRVI in Q4 2020 and held it in 3 quarters. The position peaked at $3K in Q4 2020. 228 funds tracked by Wall St. Rank hold MRVI as of Q3 2021.

  • Concourse Financial Group Securities reported no remaining Maravai LifeSciences position as of Q3 2021 after selling out during the quarter.
  • Concourse Financial Group Securities sold 29 Maravai LifeSciences shares in Q3 2021, an estimated $1.42K.
  • Concourse Financial Group Securities first reported a position in Maravai LifeSciences in Q4 2020 and held it in 3 quarters.
  • Concourse Financial Group Securities's Maravai LifeSciences position peaked at $3K in Q4 2020.
  • 228 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2021.

Based on Concourse Financial Group Securities's 13F filing for Q3 2021, filed 9 Nov 2021.